Answer
Inavolisib induces CYP enzymes in vitro and may decrease systemic exposure to warfarin, a sensitive substrate with a narrow therapeutic index, potentially reducing its efficacy.
Sources for this answer
- Itovebi 3 mg & 9mg film-coated tabletsRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked